Lantheus Holdings (LNTH) EBIT (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly EBIT came in at $81.3 million in Q1 2026, down 20.32% year-on-year from $102.1 million in Q1 2025, and up 5.37% on a QoQ basis from $77.2 million in Q4 2025.
Lantheus Holdings (LNTH) EBIT (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of EBIT data on file, last reported at $81.3 million in Q1 2026.
- On a quarterly basis, EBIT fell 20.32% year-over-year to $81.3 million in Q1 2026; TTM through Mar 2026 was $290.1 million, a 35.88% decrease from a year earlier, with the FY2025 full-year figure at $310.8 million, down 31.98% from the prior year.
- EBIT for Q1 2026 stood at $81.3 million, up from $77.2 million in the prior quarter.
- Over the last five years, EBIT for LNTH reached as high as $137.5 million in Q4 2023 and fell as low as -$171.7 million in Q4 2022.
- Historically, EBIT has averaged $73.5 million across 5 years, with a median of $88.0 million in 2025.
- Across the five-year window, EBIT tumbled 385.81% in 2022 and soared 1241.21% in 2024, its largest moves.
- Year by year, EBIT stood at -$171.7 million in 2022, then jumped by 180.08% to $137.5 million in 2023, then declined by 17.18% to $113.9 million in 2024, then sank by 32.22% to $77.2 million in 2025, then climbed by 5.37% to $81.3 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were $81.3 million in Q1 2026, $77.2 million in Q4 2025, and $43.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 81.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.33 Mn |
| Dec 31, 2025 | 77.18 Mn |
| Sep 30, 2025 | 43.62 Mn |
| Jun 30, 2025 | 87.97 Mn |
| Mar 31, 2025 | 102.07 Mn |
| Dec 31, 2024 | 113.87 Mn |
| Sep 30, 2024 | 133.74 Mn |
| Jun 30, 2024 | 102.73 Mn |
| Mar 31, 2024 | 106.64 Mn |
| Dec 31, 2023 | 137.49 Mn |
| Sep 30, 2023 | 112.36 Mn |
| Jun 30, 2023 | 124.14 Mn |
| Mar 31, 2023 | -9.34 Mn |
| Dec 31, 2022 | -171.68 Mn |
| Sep 30, 2022 | 85.74 Mn |
| Jun 30, 2022 | 63.20 Mn |
| Mar 31, 2022 | 58.93 Mn |
| Dec 31, 2021 | -35.34 Mn |
| Sep 30, 2021 | -14.33 Mn |
| Jun 30, 2021 | -26.78 Mn |